ProKidney Corp reports results for the quarter ended in June - Earnings Summary

Prokidney

10/08/2023 23:31

* ProKidney Corp  PROK.OQ  reported a quarterly adjusted
loss
of 14 cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 39 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * ProKidney Corp's reported EPS for the quarter was a loss
of 14
cents​.
    * The mean earnings estimate of analysts had fallen by
about 24.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * ProKidney Corp shares had risen by 15.2% this quarter and
gained 87.9% so far this year.
    * The company reported a quarterly loss of $9.12 million.
    * Wall Street's median 12-month price target for ProKidney
Corp is
$15.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 10:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.39          -0.14          Beat
 Mar. 31 2023      -0.39          -0.16          Beat
 Dec. 31 2022      -0.25          -0.11          Beat
 Sep. 30 2022      -0.24          -0.13          Beat